An FDA advisory panel is expected to vote on whether seven types of peptides should be sold as compounded medications.

Despite the end of nationwide shortages of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the market for compounded ...

Americans are still buying compounded versions of Ozempic and Zepbound more than a year after federal regulators declared ...

Demand for compounded GLP-1 drugs persists despite shortage resolutions ...

Even after federal shortages of the most popular weight-loss drugs ended, many medical spas are still selling copycat ...

Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains ...

Weight-loss treatments like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have been life changing for many individuals seeking to manage their weight. However, shortages and high ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you're starting a weight loss journey, you might have stumbled upon tirzepatide — the drug approved by the FDA (U.S. Food and Drug ...

Compounded forms of semaglutide and tirzepatide were being sold by dozens of compounded pharmacies from August to October ...

Add Yahoo as a preferred source to see more of our stories on Google. Hims & Hers' Super Bowl ad plugs its compounded weight loss drugs as the "affordable" solution to a "sick system," but many ...

Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...

The compounded GLP-1 market continues, even though some suppliers lack sterile-compounding licenses or have faced disciplinary action, and many add ingredients such as B vitamins.